(Q30643494)

25 June 2017

A novel molecular mechanism modulating osteoclast differentiation and function (English)

1 reference

25 June 2017

Yasuda H

1

1 reference

25 June 2017

Shima N

2

1 reference

25 June 2017

Nakagawa N

3

1 reference

25 June 2017

Yamaguchi K

4

1 reference

25 June 2017

Kinosaki M

5

1 reference

25 June 2017

Goto M

6

1 reference

25 June 2017

Mochizuki SI

7

1 reference

25 June 2017

Tsuda E

8

1 reference

25 June 2017

Morinaga T

9

1 reference

25 June 2017

Udagawa N

10

1 reference

25 June 2017

Takahashi N

11

1 reference

25 June 2017

Suda T

12

1 reference

25 June 2017

Higashio K

13

1 reference

25 June 2017

1 July 1999

1 reference

25 June 2017

1 reference

25 June 2017

25

1 reference

25 June 2017

109-113

1 reference

25 June 2017

1

1 reference

Osteoclastogenesis inhibitory factor suppresses osteoclast survival by interfering in the interaction of stromal cells with osteoclast

25 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Generation of osteoclast-inductive and osteoclastogenic cell lines from the H-2KbtsA58 transgenic mouse

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Interleukin-1 alpha activates an NF-kappaB-like factor in osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Establishment and characterization of an immortal macrophage-like cell line inducible to differentiate to osteoclasts.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Structure of the mouse osteoclastogenesis inhibitory factor (OCIF) gene and its expression in embryogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Cloning and characterization of the gene encoding human osteoprotegerin/osteoclastogenesis-inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Transforming growth factor-beta1 increases mRNA levels of osteoclastogenesis inhibitory factor in osteoblastic/stromal cells and inhibits the survival of murine osteoclast-like cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Role of osteoblasts in hormonal control of bone resorption—A hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Modulation of osteoclast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Modulation of osteoclast differentiation by local factors

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoblastic cells are involved in osteoclast formation.

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Transforming growth factor-beta stimulates the production of osteoprotegerin/osteoclastogenesis inhibitory factor by bone marrow stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Characterization of monomeric and homodimeric forms of osteoclastogenesis inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha,25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Origin of osteoclasts: mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

TRANCE (tumor necrosis factor [TNF]-related activation-induced cytokine), a new TNF family member predominantly expressed in T cells, is a dendritic cell-specific survival factor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Characterization of structural domains of human osteoclastogenesis inhibitory factor

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Immunological characterization of circulating osteoprotegerin/osteoclastogenesis inhibitory factor: increased serum concentrations in postmenopausal women with osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL

1 reference

https://api.crossref.org/works/10.1016%2FS8756-3282%2899%2900121-0

7 January 2021

10.1016/S8756-3282(99)00121-0

Identifiers

DOI

1 reference

25 June 2017

1 reference